The Effect of Probenecid on the Pharmacokinetics of Zalcitabine in HIV-Positive Patients

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Pharmaceutical Research

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/A:1016009029536PMID 8692740
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular accumulation of antineoplaston AS21 in human hepatoma cells.

  1995cited by this paper
• Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.

  1995cited by this paper
• Demonstration of organic anion transport in T lymphocytes. L-lactate and fluo-3 are target molecules.

  1994cited by this paper
• Expression of the choroid plexus sodium-nucleoside cotransporter (N3) in Xenopus laevis oocytes.

  1994cited by this paper
• Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells.

  1994cited by this paper
• Interaction of Nucleoside Analogues with the Sodium–Nucleoside Transport System in Brush Border Membrane Vesicles from Human Kidney

  1993cited by this paper
• Substrate selectivity, potential sensitivity and stoichiometry of Na(+)-nucleoside transport in brush border membrane vesicles from human kidney.

  1993cited by this paper
• Nucleoside transport in brush border membrane vesicles from human kidney.

  1992cited by this paper
• A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex.

  1990cited by this paper
• A pilot study of the bioavailability and pharmacokinetics of 2',3'-dideoxycytidine in patients with AIDS or AIDS-related complex.

  1990cited by this paper
• The Inhibitory Effect of Probenecid on Renal Excretion of Famotidine in Young, Healthy Volunteers

  1990cited by this paper
• Probenecid Inhibits the Metabolic and Renal Clearances of Zidovudine (AZT) in Human Volunteers

  1990cited by this paper
• Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS‐related complex

  1989cited by this paper
• Probenecid and zidovudine metabolism.

  1989cited by this paper
• The effect of probenecid on the renal elimination of cimetidine

  1989cited by this paper
• Quantification of dideoxycytidine in human plasma by gas chromatography/mass spectrometry.

  1988cited by this paper
• Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related Disorders

  1988cited by this paper
• Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings.

  1988cited by this paper
• Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation.

  1985cited by this paper
• Effect of probenecid on the formation and elimination of acyl glucuronides: Studies with zomepirac

  1985cited by this paper
• THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.

  1965cited by this paper
• 'Benemid,' p-(di-n-propylsulfamyl)-benzoic acid; its renal affinity and its elimination.

  1951cited by this paper
• The influence of a new benzoic acid derivative on the metabolism of paraaminosalicylic acid (PAS) and penicillin.

  1950cited by this paper

• Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters

  2023cites this paper
• Drug-Induced Alterations of Mitochondrial DNA Homeostasis in Steatotic and Nonsteatotic HepaRG Cells

  2018cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach

  2017cites this paper
• Role of Connexin and Pannexin containing channels in HIV infection and NeuroAIDS.

  2017cites this paper
• Mechanisms of HIV Neuropathogenesis: Role of Cellular Communication Systems.

  2016cites this paper
• Evaluation and Quantitative Prediction of Renal Transporter‐Mediated Drug‐Drug Interactions

  2016cites this paper
• In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery

  2014cites this paper
• Organic anion, organic cation and zwitterion transporters of the SLC22 and SLC47 superfamily (OATs, OCTs, OCTNs and MATEs)

  2013cites this paper
• Quantitative prediction of renal transporter-mediated clinical drug-drug interactions.

  2013cites this paper
• Mechanisms of Drug Interactions II: Transport Proteins

  2011cites this paper
• Therapeutic implications of renal anionic drug transporters.

  2010cites this paper
• Drugdrug interactions involving membrane transporters in the human kidney

  2006cites this paper
• Interaction of zalcitabine with human organic anion transporter 1.

  2006cites this paper
• Stavudine, Didanosine, and Zalcitabine

  2006cites this paper
• Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance

  2005cites this paper
• Drugs for HIV-Related Opportunistic Infections

  2005cites this paper
• Drug Transporters and Their Role in Tissue Distribution

  2004cites this paper
• Renal excretion mechanisms of the antiviral nucleoside analogue AM 188 IN the rat isolated perfused kidney

  2004cites this paper
• Drug Interactions Between Antiretroviral Drugs and Comedicated Agents

  2003cites this paper
• Rapid internal acyl migration and protein binding of synthetic probenecid glucuronides.

  2002cites this paper
• Role of transport proteins in drug absorption, distribution and excretion

  2001cites this paper
• Is there a pharmacokinetic interaction between foscarnet and zalcitabine during concomitant administration?

  1998cites this paper
• The Effects of Renal Impairment on the Pharmacokinetics of Zalcitabine

  1998cites this paper
• General recommendations

  1978cites this paper